Literature DB >> 10872664

Progression to invasive melanoma from malignant melanoma in situ, lentigo maligna type.

Z S Tannous1, L H Lerner, L M Duncan, M C Mihm, T J Flotte.   

Abstract

We have previously hypothesized that lesions that have been termed lentigo maligna can be divided into 2 categories: 1 represents a pigmented lesion that is a precursor to melanoma, and the other melanoma in situ. We and others have hypothesized that there is a progressive acquisition of attributes in pigmented lesions that results in malignant melanoma. Based on these 2 hypotheses, we have predicted that the intraepidermal component of invasive malignant melanomas, lentigo maligna type, should be similar to those lesions that we have termed malignant melanoma in situ, lentigo maligna type rather than lentigo maligna. The intraepidermal component of 42 consecutive cases of invasive malignant melanoma, lentigo maligna type was evaluated by all of the authors. Malignant melanoma in situ, lentigo maligna type is characterized by pagetoid spread, confluence, and nesting of atypical melanocytes. All of the cases evaluated showed features diagnostic of malignant melanoma in situ, lentigo maligna type, in the epidermis overlying the invasive dermal component. We conclude that invasive lentigo maligna melanoma arises in association with those lesions that we have termed malignant melanoma in situ, lentigo maligna type, which may represent a step in the progression between atypical melanocytic hyperplasia (lentigo maligna) and invasive melanoma. This finding supports the distinction of these entities and may have therapeutic implications.

Entities:  

Mesh:

Year:  2000        PMID: 10872664     DOI: 10.1053/hupa.2000.7640

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  6 in total

1.  Cutaneous melanoma in situ: translational evidence from a large population-based study.

Authors:  Simone Mocellin; Donato Nitti
Journal:  Oncologist       Date:  2011-05-31

2.  Treatment of Head and Neck Melanoma In Situ With Staged Contoured Marginal Excisions.

Authors:  Evan S Glazer; Caitlin F Porubsky; Jeffrey D Francis; Jamie Ibanez; Nicholas Castner; Jane L Messina; Amod A Sarnaik; Michael A Harrington; C Wayne Cruse; Vernon K Sondak; Jonathan S Zager
Journal:  Ann Plast Surg       Date:  2017-06       Impact factor: 1.539

Review 3.  Treatment of periocular lentigo maligna with topical 5% Imiquimod: a review.

Authors:  Inga Neumann; R Patalay; M Kaushik; H Timlin; C Daniel
Journal:  Eye (Lond)       Date:  2022-07-14       Impact factor: 4.456

Review 4.  Current and emerging technologies in melanoma diagnosis: the state of the art.

Authors:  Estee L Psaty; Allan C Halpern
Journal:  Clin Dermatol       Date:  2009 Jan-Feb       Impact factor: 3.541

5.  Prostate carcinoma metastatic to the skin as an extrammamary Paget's disease.

Authors:  Eugen Bogdan Petcu; Aldo Gonzalez-Serva; Robert G Wright; Mark Slevin; Klara Brinzaniuc
Journal:  Diagn Pathol       Date:  2012-08-18       Impact factor: 2.644

6.  Histological Peripheral Margins and Recurrence of Melanoma In Situ Treated with Wide Local Excision.

Authors:  Francisco S Moura; Lucy E Homer; Stuart W McKirdy
Journal:  J Skin Cancer       Date:  2020-10-29
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.